News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
AOL.com Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
USANA Health Sciences (NYSE: USNA) lowered its full-year outlook due to increased digital customer acquisition costs for its Hiya brand and a packaging issue with Rise Wellness, resulting in significant revenue and margin pressure. Despite these challenges, the core nutrition business performed as expected, …
Key Points Usana's Q2 earnings came in way below expectations, and sales were also lower than expected. Usana now expects to record a loss for the full-year period. The company also lowered its full-year sales forecast. 10 stocks we like better than USANA Health …
Zacks Research has downgraded USANA Health Sciences (NYSE:USNA) to a "strong sell" from "hold," contributing to a consensus "sell" rating for the stock. This follows USANA's recent quarterly report, where the company missed EPS and revenue estimates and issued a lower-than-expected FY2026 EPS guidance. …
USANA Health Sciences (NYSE:USNA) has been downgraded to a "Hold" rating by Wall Street Zen, adding to previous downgrades from other analysts, resulting in an overall consensus rating of "Reduce." This follows the company missing earnings expectations in its latest quarter, reporting an adjusted …
USANA Health Sciences (USNA) experienced a significant stock drop of 34.2% after reporting a Q2 2026 loss per share of US$1.16 on revenue of US$223.3m, compounded by a US$29m non-cash goodwill impairment related to its Hiya brand. The company swung from a profit of …
USANA Health Sciences (USNA) experienced a significant share price drop and reported a Q2 2026 net loss, lowered full-year guidance, and a $29 million goodwill impairment. Despite these setbacks, Simply Wall St's analysis suggests the stock is undervalued with a Price-to-Sales ratio of 0.3x …
USANA Health Sciences (USNA) reported a significant Q2 2026 loss of 7 cents per share on $223 million revenue, widely missing analyst expectations, leading to a 28% stock decline. The loss was attributed to a non-cash goodwill impairment for its Hiya unit, a packaging …
Shares of USANA Health Sciences (USNA) dropped significantly after the company reported second-quarter 2026 results that missed Wall Street's revenue and earnings expectations, posting an adjusted loss per share against forecasts for a profit. This steep decline overshadowed the reaffirmation of its full-year revenue …
USANA Health Sciences, Inc. announced its Q2 2026 financial results, with net sales of $223 million and a net loss of $21.4 million. The company experienced mixed performance, with its Core Nutritional business meeting expectations but its ventures, Hiya and Rise Wellness, performing below …
Kevin Guest, Chairman and CEO of USANA Health Sciences, offers five practical tips to cultivate happiness during August's Happiness Happens Month. These tips include noticing existing good, creating moments of joy, recognizing others, helping without being asked, and protecting time for important people and …
USANA Health Sciences CEO Kevin Guest shares five happiness tips for both work and home to celebrate Happiness Happens Month in August. He emphasizes intentionally noticing good things, creating joyful moments, recognizing others, helping without being asked, and protecting time for important relationships. Guest …
Lazard Asset Management LLC has acquired a new stake of 72,395 shares in USANA Health Sciences, Inc. (NYSE:USNA) worth approximately $1.26 million. This investment gives Lazard Asset Management a 0.39% stake in the company, where institutional investors and hedge funds collectively own 54.25%. USANA …
USANA Health Sciences reported a Q2 2026 net loss of $(21.4) million, including a $29.1 million impairment charge, and updated its fiscal year 2026 sales outlook downward due to underperformance in its Hiya and Rise Wellness ventures. The company's core nutritional business performed as …
USANA Health Sciences (USNA) reported a Q2 loss of $0.07 per share, missing the Zacks Consensus Estimate of $0.43, and revenues of $223.27 million, falling short of the $235.85 million reported a year ago. Despite outperforming the market year-to-date with a 16.4% stock gain, …
USANA Health Sciences (NYSE:USNA) reported quarterly earnings, missing analyst estimates with a loss of $0.07 per share against a projected $0.43 profit, and revenue of $223.27 million, below the $235 million estimate. Shares traded up $0.05 to $22.89, giving the company a market capitalization …
USANA Health Sciences reported a Q2 2026 net loss of $(21.4) million, a significant swing from a net gain of $9.7 million in the prior year, primarily due to a $29.1 million goodwill impairment charge related to its Hiya reporting unit. The company also …
USANA Health Sciences (USNA) is set to report its Q2 earnings this Tuesday. The market expects flat year-on-year revenue, a slowdown from last year's 10.8% increase, despite analysts reconfirming estimates. The company has a history of missing Wall Street's revenue estimates multiple times over …
USANA Health Sciences, Inc. (NYSE: USNA) reported total revenue of $925.26 million USD last year. The Core Nutritional segment was the top performer, generating $775.45 million USD, while China was the largest regional contributor with $381.82 million USD in revenue.
USANA Health Sciences announced the results of a 12-week consumer study for its skincare supplement, Glow, showing significant improvements in participants' skin. The study, involving 36 individuals in the U.S. and Mexico, reported high percentages of brighter-looking, more radiant, and even-toned skin, along with …
USANA Health Sciences has introduced Glow, a cellular nutrition supplement designed to promote healthy, radiant skin. A 12-week consumer trial involving 36 participants showed that over 97% experienced improvements in brightness and skin tone, with significant gains in hydration, firmness, and elasticity. The product's …
USANA Health Sciences (USNA) had 1,580 employees worldwide as of March 2026, marking a 4.6% decline from 2023. The company's workforce is primarily concentrated in the United States, Philippines, and Canada, with Mexico being its fastest-growing location. USANA is actively hiring, though job postings …
USANA Health Sciences Inc (USNA) currently boasts a robust financial score of 8.24, ranking 12th in the Food & Tobacco industry. The company reported a quarterly revenue of $250.22 million, showing a 0.27% year-over-year increase, and a significant 20.07% year-over-year increase in net profit. …
This article analyzes Usana Health Sciences Inc. (USNA) using AI models to determine its effect on rotational strategy timing. It identifies near-term weak sentiment, no clear price positioning, and offers institutional trading strategies including long, momentum breakout, and short positions. The analysis also provides …
USANA Health Sciences (NYSE:USNA) is scheduled to announce its Q2 2026 earnings on Tuesday, August 4th, with analysts expecting $0.43 EPS on $235.0 million in revenue. This follows a strong previous quarter where the company surpassed estimates with $0.61 EPS and $250.22 million in …
USANA Health Sciences CIO Benedict Peter increased his stock holdings on July 25, 2026, through a combination of restricted stock unit vesting and open market transactions. This move, disclosed on July 27, 2026, demonstrates executive confidence in the nutritional supplement and wellness company (NYSE: …
This article provides a detailed historical cash flow statement for USANA Health Sciences Inc (USNA), offering both quarterly and annual data for operating, investing, and financing activities through FY2026Q1. It also includes definitions and explanations of key cash flow metrics like operating cash flow, …
This article reports on a Form 4 filing for USANA Health Sciences Inc. on July 27. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a material change in the holdings of …
Search by ticker symbol or company name and select a result to open its chart.